Home › NDC Lookup › RxCUI directory › RxCUI 860771

Trimethobenzamide hydrochloride 300 MG Oral Capsule — RxCUI 860771

RxNorm drug concept · Semantic clinical drug
RxCUI 860771 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI860771
Official nameTrimethobenzamide hydrochloride 300 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known astrimethobenzamide HCl 300 MG Oral Capsule
FDA products mapped4
Package NDCs mapped8
Reported Medicaid activity (SDUD)57 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Trimethobenzamide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's an anti-nausea medication approved for adults to treat two specific situations: nausea and vomiting after surgery, and nausea caused by gastroenteritis — that stomach bug that...
  • What exactly does trimethobenzamide treat?
  • That depends on what you're taking. Trimethobenzamide can interact with a number of common drugs — including sleep aids, opioid painkillers, anti-anxiety medications, and antipsych...
  • Can I take this with my other medications?
📖 Read our full Trimethobenzamide guide →

🕸️ Concept Web — How Trimethobenzamide hydrochloride 300 MG Oral Caps... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Trimethobenzamide hydrochloride 300 MG Oral Capsule RxCUI 860771

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Trimethobenzamide 38685
    • Trimethobenzamide hydrochloride 57227
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Trimethobenzamide Oral Capsule 374227
    • Trimethobenzamide hydrochloride Oral Capsule 2648185
    • Trimethobenzamide Oral Product 1163378
    • Trimethobenzamide Pill 1163379
    • Trimethobenzamide hydrochloride Oral Product 2662082
    • Trimethobenzamide hydrochloride Pill 2659247
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Trimethobenzamide hydrochloride 300 MG 860770

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Trimethobenzamide hydrochloride 300 MG SCDC · 860770
  • Trimethobenzamide Oral Capsule SCDF · 374227
  • Trimethobenzamide hydrochloride Oral Capsule SCDFP · 2648185
  • Trimethobenzamide Oral Product SCDG · 1163378
  • Trimethobenzamide Pill SCDG · 1163379
  • Trimethobenzamide hydrochloride Oral Product SCDGP · 2662082
  • Trimethobenzamide hydrochloride Pill SCDGP · 2659247

📦 FDA Products & Package NDCs

4 products · 8 package NDCs
8 package NDCs map to RxCUI 860771 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
23155-0180-01 100 CAPSULE in 1 BOTTLE (23155-180-01) Trimethobenzamide Hydrochloride Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2023-11-21
43386-0660-03 30 CAPSULE in 1 BOTTLE (43386-660-03) Trimethobenzamide Hydrochloride Lupin Pharmaceuticals,Inc. 2011-01-17
43386-0660-24 100 CAPSULE in 1 BOTTLE (43386-660-24) Trimethobenzamide Hydrochloride Lupin Pharmaceuticals,Inc. 2011-01-17
62135-0773-30 30 CAPSULE in 1 PACKAGE (62135-773-30) Trimethobenzamide Hydrochloride Chartwell RX, LLC 2023-11-21
62135-0773-90 90 CAPSULE in 1 PACKAGE (62135-773-90) Trimethobenzamide Hydrochloride Chartwell RX, LLC 2023-11-21
71335-0800-01 10 CAPSULE in 1 BOTTLE (71335-0800-1) Trimethobenzamide Hydrochloride Bryant Ranch Prepack 2012-01-12
71335-0800-02 15 CAPSULE in 1 BOTTLE (71335-0800-2) Trimethobenzamide Hydrochloride Bryant Ranch Prepack 2012-01-12
71335-0800-03 30 CAPSULE in 1 BOTTLE (71335-0800-3) Trimethobenzamide Hydrochloride Bryant Ranch Prepack 2012-01-12
Observed labelers: Bryant Ranch Prepack (3) · Chartwell RX, LLC (2) · Lupin Pharmaceuticals,Inc. (2) · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$17.9997
Range $17.9997–$17.9997 · middle 50% $17.9997–$17.9997 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.